Skip to content

Change in AP at other companies

ALN
Alnylam PharmaceuticalsALNY
-$176.03M-11.6%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$2.3M-294%
Regenxbio logo
RegenxbioRGNX
$349K+110%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$139K+893%
Opko Health logo
Opko HealthOPK
$3.5M-69.5%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
-$2.71M-540%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's change in AP?
Tectonic Therapeutics (TECX) reported change in AP of $1.38M in Q1 2026.
How has Tectonic Therapeutics's change in AP changed year-over-year?
Tectonic Therapeutics's change in AP decreased by 12.7% year-over-year, from $1.58M to $1.38M.
What is the long-term trend for Tectonic Therapeutics's change in AP?
Over 2 years (2021 to 2024), Tectonic Therapeutics's change in AP has grown at a 32.9% compound annual growth rate (CAGR), from $804K to -$1.42M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.